Yale Investigators' Lead Grant Awarded as Part of the NIH HEAL Initiative on Opioids
Dr. Gail D’Onofrio, Professor of Emergency Medicine and Public Health and Dr. David Fiellin, Professor of Medicine, Emergency Medicine and Public Health are lead investigators in a $25.5 Million study being conducted by the National Drug Abuse Treatment Clinical Trials Network’s New England Consortium Node.
Yale Researchers Awarded Grant to Study Smoking Treatment in People With HIV
Drs. E. Jennifer Edelman and Steven L. Bernstein received a grant award to address tobacco smoking addiction among people with HIV. The National Cancer Institute grant, totaling more than $3 million, supports a five-year research project.
Yale and Mayo Clinic Awarded FDA Grant to Study Opioid Prescribing and Use
Yale University and Mayo Clinic have been awarded a grant for up to $5.3 million over two years by the U.S. Food and Drug Administration (FDA) to study patients’ experiences with pain and use of opioids prescribed for acute pain. This project is part of the Center of Excellence in Regulatory Science and Innovation (CERSI), a joint effort between Yale, Mayo Clinic, and the FDA. The study will be conducted in collaboration with Regional Health of Rapid City, S.D., and University of Alabama at Birmingham (UAB).
Better Science, Better Lives: Women's Health Research at Yale is Working for You
Across the country, it’s becoming clearer every day: We must study the health of women. We must study the influence of sex-and-gender differences on health. And it’s time for all aspects of medical research and practice to embrace this change.
Yonkers, Forray Co-PIs on New Grant to Study Medication Delivery for Pregnant Women with Opioid Use Disorders
Kimberly Yonkers, MD, Professor of Psychiatry, of Epidemiology (Chronic Diseases) and of Obstetrics, Gynecology, and Reproductive Services, and Ariadna Forray, MD, Associate Professor of Psychiatry, are co-principal investigators on a new $5.5 million grant to study models to improve delivery of office-based medication treatment for pregnant women with opioid use disorder in prenatal clinics.
YSPH Convenes Experts to Examine Alcohol’s Role in Cancer
Chronic alcohol abuse is considered to be an important risk factor for disease worldwide. In addition, alcohol and its metabolite, acetaldehyde, are recognized as carcinogens that contribute to four percent of cancer deaths. Although scientific studies began to show this association over 100 years ago, the role of alcohol in chronic diseases such as cancer is still not well understood by the public and medical professionals. The 4th International Conference on Alcohol and Cancer was organized by Vasilis Vasiliou, PhD, the Susan Dwight Bliss Professor of Epidemiology, sponsored by the Department of Environmental Health Sciences of the Yale School of Public Health, and supported by an R13 grant from the National Institute of Alcohol Abuse and Alcoholism (NIAAA). The conference, held in Newport, R.I., brought together 75 international scholars with special interest in alcohol and/or cancer.
Child deaths from opioids nearly tripled in recent years, says Yale study
Close to 9,000 children and teens in the United States died from opioid poisonings over the last two decades, representing a nearly three-fold increase in mortality rates, Yale researchers said. These findings illustrate how the opioid epidemic continues to evolve and harm children even as efforts to confront the crisis through treatment and limits on opioid prescribing ramp up, they said.
Prevalent misconceptions about opioid use disorders in the United States produce failed policy and public health responses
The current crisis of illicit opioid use and overdose has its roots in two prior epidemics, misconceptions about treatment of chronic pain, and stigma against drug users. Correcting historical inaccuracies and addressing stigma are key to amelioration of the crisis.